The goal of this Research Program is to design, develop, and clinically test an autologous HIV immunotherapy capable of eliciting therapeutic immune responses and which is comprised of autologous monocyte-derived dendritic cells modified to express selected autologous HIV proteins representing a multiplicity of patient-specific quasispecies

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
N01AI60019-9-0-1
Application #
8748839
Study Section
Project Start
2006-09-30
Project End
2015-09-30
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$5,415,284
Indirect Cost
Name
Argos Therapeutics, Inc.
Department
Type
DUNS #
155355030
City
Durham
State
NC
Country
United States
Zip Code
27704